Roffman Miller Associates Inc. PA grew its position in AMETEK, Inc. (NYSE:AME – Free Report) by 1.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 135,247 shares of the technology company’s stock after purchasing an additional 1,277 shares during the quarter. AMETEK makes up 1.5% of Roffman Miller Associates Inc. PA’s investment portfolio, making the stock its 28th largest position. Roffman Miller Associates Inc. PA’s holdings in AMETEK were worth $24,380,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB grew its holdings in AMETEK by 4.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,450 shares of the technology company’s stock worth $261,000 after acquiring an additional 63 shares during the period. Geneos Wealth Management Inc. grew its holdings in AMETEK by 42.9% in the fourth quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. AlphaMark Advisors LLC grew its holdings in AMETEK by 2.1% in the fourth quarter. AlphaMark Advisors LLC now owns 3,348 shares of the technology company’s stock valued at $604,000 after purchasing an additional 70 shares during the last quarter. Quotient Wealth Partners LLC grew its holdings in AMETEK by 3.9% in the fourth quarter. Quotient Wealth Partners LLC now owns 1,843 shares of the technology company’s stock valued at $332,000 after purchasing an additional 70 shares during the last quarter. Finally, Howard Capital Management Inc. grew its holdings in AMETEK by 5.0% in the fourth quarter. Howard Capital Management Inc. now owns 1,501 shares of the technology company’s stock valued at $271,000 after purchasing an additional 72 shares during the last quarter. 87.43% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
AME has been the topic of several research reports. Truist Financial upped their target price on AMETEK from $221.00 to $222.00 and gave the company a “buy” rating in a report on Thursday, January 16th. Bank of America raised AMETEK from a “neutral” rating to a “buy” rating and upped their target price for the company from $195.00 to $225.00 in a report on Monday, December 16th. BNP Paribas raised AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 target price on the stock in a report on Thursday, January 16th. StockNews.com raised AMETEK from a “hold” rating to a “buy” rating in a report on Friday. Finally, Robert W. Baird lowered their target price on AMETEK from $200.00 to $197.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $204.67.
AMETEK Stock Performance
NYSE AME opened at $186.11 on Monday. The business’s 50-day moving average price is $182.95 and its 200 day moving average price is $178.36. AMETEK, Inc. has a twelve month low of $149.03 and a twelve month high of $198.33. The company has a market capitalization of $43.05 billion, a PE ratio of 31.38, a price-to-earnings-growth ratio of 2.77 and a beta of 1.16. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15.
AMETEK (NYSE:AME – Get Free Report) last released its earnings results on Tuesday, February 4th. The technology company reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.02. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.82 billion. During the same period in the prior year, the business posted $1.68 earnings per share. The firm’s revenue for the quarter was up 1.8% compared to the same quarter last year. On average, research analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current year.
AMETEK Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be given a dividend of $0.31 per share. The ex-dividend date is Friday, March 14th. This is an increase from AMETEK’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 0.67%. AMETEK’s dividend payout ratio is 18.89%.
AMETEK declared that its board has approved a share repurchase program on Friday, February 7th that permits the company to repurchase $1.25 billion in outstanding shares. This repurchase authorization permits the technology company to repurchase up to 2.9% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.
Insider Buying and Selling
In other news, insider Emanuela Speranza sold 6,747 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $195.90, for a total value of $1,321,737.30. Following the transaction, the insider now directly owns 30,460 shares in the company, valued at $5,967,114. This trade represents a 18.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.61% of the stock is currently owned by company insiders.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
See Also
- Five stocks we like better than AMETEK
- What Investors Need to Know About Upcoming IPOs
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is a Death Cross in Stocks?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.